Journal
IMMUNITY
Volume 26, Issue 5, Pages 629-641Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2007.03.016
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI072627-01, R01 AI072627, R01 AI044130, AI044130, AI072627] Funding Source: Medline
- NIDDK NIH HHS [R01 DK053561-05] Funding Source: Medline
Ask authors/readers for more resources
Fas (also known as Apo-1 and CD95) receptor has been suggested to control T cell expansion by triggering T cell-autonomous apoptosis. This paradigm is based on the extensive lymphoproliferation and systemic autoimmunity in mice and humans lacking Fas or its ligand. However, with systemic loss of Fas, it is unclear whether T cell-extrinsic mechanisms contribute to autoimmunity. We found that tissue-specific deletion of Fas in mouse antigen-presenting cells (APCs) was sufficient to cause systemic autoimmunity, implying that normally APCs are destroyed during immune responses via a Fas-mediated mechanism. Fas expression by APCs was increased by exposure to microbial stimuli. Analysis of mice with Fas loss restricted to T cells revealed that Fas indeed controls autoimmune T cells, but not T cells responding to strong antigenic stimulation. Thus, Fas-dependent elimination of APCs is a major regulatory mechanism curbing autoimmune responses and acts in concert with Fas-mediated regulation of chronically activated autoimmune T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available